| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +100.00% | +7.84% | +1.12% | +6.72% | +6.72% | — |
| 14d | 2 | +100.00% | +13.75% | +0.46% | +13.29% | +13.29% | — |
| 30d | 2 | +50.00% | +1675.72% | -2.21% | +1677.92% | +1677.92% | — |
| 60d | 2 | +50.00% | +783.14% | +3.03% | +780.12% | +780.12% | — |
| 90d | 2 | +100.00% | +641.70% | +6.53% | +635.17% | +635.17% | — |
| 180d | 2 | +50.00% | +281.18% | +11.74% | +269.43% | +269.43% | — |
| 1y | 2 | +50.00% | +123.90% | +14.36% | +109.54% | +109.54% | — |
| 2y | 2(1 pending) | +100.00% | +186.81% | +30.65% | +156.15% | +156.15% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| AGL AGILON HEALTH, INC. | SALE Chief Technology Officer | 330 | $26.88 | $8.9K | 38,236 | Apr 15, 2026 | Apr 16, 2026 ↗ | View → |
| AGL AGILON HEALTH, INC. | SALE Chief Technology Officer | 96 | $22.68 | $2.2K | 38,566 | Apr 14, 2026 | Apr 16, 2026 ↗ | View → |
| AGL AGILON HEALTH, INC. | SALE Chief Technology Officer | 480 | $9.75 | $4.7K | 10,662 | Apr 1, 2026 | Apr 3, 2026 ↗ | View → |
| AGL AGILON HEALTH, INC. | PURCHASEGRANT Stock grant | 28,000 | — | — | 38,662 | Apr 1, 2026 | Apr 3, 2026 ↗ | View → |
| AGL AGILON HEALTH, INC. | SALE Chief Technology Officer | 6,477 | $0.60 | $3.9K | 278,607 | Mar 9, 2026 | Mar 11, 2026 ↗ | View → |
| AGL AGILON HEALTH, INC. | PURCHASE Chief Technology Officer | 18,448 | — | — | 285,084 | Mar 9, 2026 | Mar 11, 2026 ↗ | View → |
| AGL AGILON HEALTH, INC. | SALE Chief Technology Officer | 8,226 | $5.53 | $45.5K | 266,636 | Apr 15, 2025 | Apr 16, 2025 ↗ | View → |
| AGL AGILON HEALTH, INC. | SALE Chief Technology Officer | 2,808 | $5.60 | $15.7K | 274,862 | Apr 14, 2025 | Apr 16, 2025 ↗ | View → |
| AGL AGILON HEALTH, INC. | PURCHASEGRANT Stock grant | 192,308 | — | — | 192,308 | Apr 1, 2025 | Apr 3, 2025 ↗ | View → |
| AGL AGILON HEALTH, INC. | PURCHASEGRANT Stock grant | 122,550 | — | — | 277,670 | Apr 1, 2025 | Apr 3, 2025 ↗ | View → |
| AGL AGILON HEALTH, INC. | PURCHASE Chief Technology Officer | 9,429 | — | — | 158,431 | Mar 14, 2025 | Mar 18, 2025 ↗ | View → |
| AGL AGILON HEALTH, INC. | SALE Chief Technology Officer | 3,311 | $4.05 | $13.4K | 155,120 | Mar 14, 2025 | Mar 18, 2025 ↗ | View → |
| AGL AGILON HEALTH, INC. | PURCHASEGRANT Stock grant | 184,502 | — | — | 184,502 | Apr 15, 2024 | Apr 17, 2024 ↗ | View → |
| AGL AGILON HEALTH, INC. | PURCHASEGRANT Stock grant | 112,108 | — | — | 152,058 | Apr 15, 2024 | Apr 17, 2024 ↗ | View → |
| AGL AGILON HEALTH, INC. | SALE Chief Technology Officer | 3,056 | $4.95 | $15.1K | 149,002 | Apr 14, 2024 | Apr 17, 2024 ↗ | View → |
| AGL AGILON HEALTH, INC. | PURCHASE Chief Technology Officer | 5,434 | — | — | 41,833 | Mar 14, 2024 | Mar 18, 2024 ↗ | View → |
| AGL AGILON HEALTH, INC. | SALE Chief Technology Officer | 1,883 | $5.23 | $9.8K | 39,950 | Mar 14, 2024 | Mar 18, 2024 ↗ | View → |
| AGL AGILON HEALTH, INC. | PURCHASEGRANT Stock grant | 37,971 | — | — | 37,971 | Apr 14, 2023 | Apr 18, 2023 ↗ | View → |
| AGL AGILON HEALTH, INC. | PURCHASEGRANT Stock grant | 21,961 | — | — | 37,756 | Apr 14, 2023 | Apr 18, 2023 ↗ | View → |
| AGL AGILON HEALTH, INC. | SALE Chief Technology Officer | 1,357 | $28.46 | $38.6K | 36,399 | Apr 14, 2023 | Apr 18, 2023 ↗ | View → |
| AGL AGILON HEALTH, INC. | PURCHASEGRANT Stock grant | 35,664 | — | — | 35,664 | Apr 14, 2022 | Apr 20, 2022 ↗ | View → |
| AGL AGILON HEALTH, INC. | PURCHASEGRANT Stock grant | 10,837 | — | — | 16,271 | Apr 14, 2022 | Apr 20, 2022 ↗ | View → |
| AGL AGILON HEALTH, INC. | SALE Chief Technology Officer | 476 | $23.07 | $11.0K | 15,795 | Apr 14, 2022 | Sep 29, 2022 ↗ | View → |
| AGL AGILON HEALTH, INC. | PURCHASEGRANT Stock grant | 5,434 | — | — | 5,434 | Apr 14, 2021 | Apr 16, 2021 ↗ | View → |
| AGL AGILON HEALTH, INC. | PURCHASEGRANT Stock grant | 129,533 | — | — | 129,533 | Apr 14, 2021 | Apr 16, 2021 ↗ | View → |